N/A
Completed N=527
DEXYCU (Dexamethasone Intraocular Suspension) 9% Retrospective Study 001
Source: ClinicalTrials.gov NCT04290676 ↗Enrolled (actual)
527
Serious AEs
0.0%
Results posted
May 2021
Primary outcomePrimary: Percentage of Eyes With Anterior Chamber Cell Grade 0 — 65 percentage of eyes
Summary
Retrospective study to provide clinical outcomes with DEXYCU (dexamethasone intraocular suspension) 9%.
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Percentage of Eyes With Anterior Chamber Cell Grade 0 |
65 | — |
Eligibility Criteria
Inclusion Criteria
- Male and Female subjects at least 18 years of age
- Subjects who underwent cataract surgery from 12Mar2019 to 15Dec2019 and received DEXYCU
Exclusion Criteria
- Subjects who underwent cataract surgery and did not receive DEXYCU
Data sourced from ClinicalTrials.gov (NCT04290676). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.